NanoGuard Technologies develops low-temperature medical device sterilization solutions utilizing proprietary Cold Plasma technology. The company serves the medical and agricultural industries by providing residue-free pathogen reduction methods as an alternative to traditional chemical treatments.
Subscribe to see NanoGuard Technologies, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
NanoGuard Technologies, Inc. is a medical technology company headquartered in Saint Louis, United States. It has raised at least $11.2M across the 3 funding rounds on record. Its most recent funding round, SBIR phase II grant, raised $2M in January 2025. Xcout tracks 6 named people at NanoGuard Technologies, Inc., including Edward Briscoe (Director).
As of 16 November 2026. Source: Xcout Intel.
At least $11.2M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SBIR phase II grant | $2M | 5 named | |
| SEC Form D filing | $3.2M | — | |
| SEC Form D filing | $6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of NanoGuard Technologies, Inc.'s closest competitors — see the full list of competitors and alternatives →
Plasmology4, Inc. is a medical devices company based out of Scottsdale, Arizona, United States. The company specializes in developing advanced medical device technologies.
Chitozan Health develops patented silver chitosan antimicrobial technologies for textile coatings, barrier packaging, and advanced wound care applications. The company serves medical, industrial, and consumer markets by providing sustainable finishes that eradicate bacteria, fungi, and viruses while minimizing chemical leaching and silver content.
Neuro-Vascular Research & Design Corp develops artificial intelligence-powered intraoperative neuromonitoring (IONM) platforms and precision hardware for surgical environments. The company's technology provides real-time data analysis to help healthcare providers detect neurological risks and guide surgical decision-making during high-risk surgeries.
iMed Technology, Inc. is a US-based medical device manufacturer and business entity headquartered in Texas, specializing in single-use wound care and clinical products.
Tiger Biotherapeutics Inc. is a regenerative medicine company that develops and provides advanced cellular, acellular, and matrix-like products (CAMPs) for wound care, aesthetics, and tissue science. The company serves healthcare providers and patients by offering solutions for tissue repair, wound closure, and reconstructive or cosmetic applications.
Sava Technologies develops a minimally invasive biosensor platform designed for real-time continuous health monitoring beyond glucose alone, including metrics like lactate, ketones, and cortisol. The company provides affordable, multi-molecule detection technology aimed at managing chronic conditions and general wellbeing.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about NanoGuard Technologies, Inc.? Suggest a correction · Work at NanoGuard Technologies, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.